TABLE 2.
Outcomes among 156 female subjects presenting with unilateral breast cancer
| 5-year % (95 % CI) |
10-year % (95 % CI) |
Unadjusted p value | p value adjusted for age and stage | |
|---|---|---|---|---|
| Local-regional recurrence | ||||
| Overall | 96.2 (92.5–100) | 83.7 (72.0–97.2) | ||
| Lumpectomy | 95.0 (88.3–100) | 80.0 (64.5–98.7) | 0.57 | 0.38 |
| Mastectomy | 97.0 (92.9–100) | 92.4 (83.2–100) | ||
| New contralateral primary breast cancer | ||||
| Overall | 97.2 (94.1–100) | 72.6 (58.3–90.5) | ||
| Lumpectomy or UM | 92.6 (84.9–100) | 64.3 (47.9–86.4) | 0.03 | 0.03 |
| BM | 100 | 83.3 (58.3–100) | ||
| Any subsequent breast cancer event | ||||
| Overall | 84.1 (77.0–91.8) | 56.4 (42.5–74.9) | ||
| Lumpectomy | 89.4 (80.0–100) | NAa | 0.51 | 0.36 |
| UM | 83.6 (64.9–100) | NAa | ||
| BM | 79.7 (68.6–92.5) | NAa | ||
UM unilateral mastectomy, BM bilateral mastectomy, NA not available
a
Sample size and number remaining at risk were too small to estimate